1. Home
  2. YEXT vs RCUS Comparison

YEXT vs RCUS Comparison

Compare YEXT & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YEXT
  • RCUS
  • Stock Information
  • Founded
  • YEXT 2006
  • RCUS 2015
  • Country
  • YEXT United States
  • RCUS United States
  • Employees
  • YEXT N/A
  • RCUS N/A
  • Industry
  • YEXT EDP Services
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • YEXT Technology
  • RCUS Health Care
  • Exchange
  • YEXT Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • YEXT 1.0B
  • RCUS 906.4M
  • IPO Year
  • YEXT 2017
  • RCUS 2018
  • Fundamental
  • Price
  • YEXT $8.47
  • RCUS $10.23
  • Analyst Decision
  • YEXT Strong Buy
  • RCUS Buy
  • Analyst Count
  • YEXT 4
  • RCUS 8
  • Target Price
  • YEXT $9.44
  • RCUS $20.86
  • AVG Volume (30 Days)
  • YEXT 651.2K
  • RCUS 855.1K
  • Earning Date
  • YEXT 09-03-2025
  • RCUS 08-07-2025
  • Dividend Yield
  • YEXT N/A
  • RCUS N/A
  • EPS Growth
  • YEXT N/A
  • RCUS N/A
  • EPS
  • YEXT N/A
  • RCUS N/A
  • Revenue
  • YEXT $434,450,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • YEXT $8.92
  • RCUS N/A
  • Revenue Next Year
  • YEXT $5.14
  • RCUS $28.73
  • P/E Ratio
  • YEXT N/A
  • RCUS N/A
  • Revenue Growth
  • YEXT 8.38
  • RCUS N/A
  • 52 Week Low
  • YEXT $4.69
  • RCUS $6.50
  • 52 Week High
  • YEXT $9.15
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • YEXT 58.93
  • RCUS 64.20
  • Support Level
  • YEXT $8.38
  • RCUS $9.14
  • Resistance Level
  • YEXT $8.67
  • RCUS $9.62
  • Average True Range (ATR)
  • YEXT 0.20
  • RCUS 0.50
  • MACD
  • YEXT 0.01
  • RCUS 0.12
  • Stochastic Oscillator
  • YEXT 77.65
  • RCUS 99.25

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: